Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.

Yahui YuHui YangXiaojia YuXiaopeng HuWei WangXiaoyong YangHang LiuLiang RenXiaodong ZhangXin FengLihong Liu

Published in: Journal of clinical pharmacy and therapeutics (2020)

The KDIGO and RA/BTS CPGs were strongly recommended. Not only the quality of the PJP prophylaxis CPGs needs to be improved during the development progress, but also the specific recommendations should be further refined.

Keyphrases

rheumatoid arthritis
quality improvement
disease activity
ankylosing spondylitis
intensive care unit
patient reported outcomes
extracorporeal membrane oxygenation